A global public health crisis hidden in plain sight
Every year, over one million people die from medicines that were never real. Counterfeit and falsified drugs are not a niche concern. They are one of the most lethal and least-addressed public health challenges of our time.
The numbers the world cannot ignore
1 in 3
Medicines consumed across Africa, South America and Asia are falsified.
1M
Deaths per year attributed to counterfeit medicine.
$200Bn
Annual economic damage from falsified medical products.
+38%
Increase reported counterfeits across the world since 2020.
1 in 3
Describe the product here. Include important features, specifications and other relevant details.
Describe the product here. Include important features, specifications and other relevant details.
Current iniatives focus on supply chain,
not the point of use.
International and national initiatives - including the EU Falsified Medicines Directive (FMD), Sproxil, and the US Global Strategic Framework for SSFFC Medical Products - have made real progress securing pharmaceutical supply chains. But these systems share a critical limitation: they protect the route from manufacturer to pharmacy. They cannot detect the counterfeit that is already in the patient's hand and informal channels.
The gap Medlens™ fills
Detection where it matter most: the moment of use
Works on any smartphone
No expensive hardware needed.
Works on packaging & pills
Detects counterfeit across both.
No manufacturer involvement
Medlens™ works independently.
In or outside supply chain
Works no matter where it came from.
